Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZLI in CF with Chronic Burkholderia Infection
NCT01059565Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Feb 2010
- Primary completion
- Sep 2011
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of aztreonam in cystic fibrosis (CF), Burkholderia infection, sponsored by Gilead Sciences. Started Feb 2010; status: completed.
02
Drugs
aztreonam
03
Conditions
cystic fibrosis (CF)Burkholderia infection
Beyond the preview
Go deeper on NCT01059565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01059565.